![]() |
市場調查報告書
商品編碼
1859793
全球生物肥料和生物農藥市場:預測至2032年-按產品類型、形態、應用方法、作物類型和地區分類的分析Biofertilizers & Biopesticides Market Forecasts to 2032 - Global Analysis By Product Type, Form, Mode of Application, Crop Type, and By Geography |
||||||
根據 Stratistics MRC 的數據,全球生物肥料和生物農藥市場預計到 2025 年將達到 92 億美元,到 2032 年將達到 189 億美元,預測期內複合年成長率為 10.9%。
生物肥料和生物農藥利用有益微生物、昆蟲病原體和植物萃取物來改善養分循環、抑制病原體並提升土壤健康,是合成化學物質的替代方案。這些農藥支持可再生農業,減少食品中的殘留,同時也能發揮生態系服務功能。永續性政策、消費者需求以及提高穩定性和延長保存期限的配方創新推動了市場成長。
根據美國農業部(USDA)的數據,2017 年至 2022 年,美國作物生產中生物肥料和生物農藥的使用量增加了 12%。
對有機食品的需求日益成長
消費者對有機和無殘留食品的需求不斷成長,是生物肥料和生物農藥市場發展的關鍵驅動力。為了滿足監管標準和消費者對永續性、減少化學殘留和更清潔標籤的期望,農民和食品品牌正在採用微生物投入品。這種消費者偏好推動了田間試驗的增加、採購預算的增加,以及農業投入品公司和生技開發商之間合作的加強。此外,有機農產品的溢價和出口機會改善了農場的經濟效益,使生物基投入品具有商業性吸引力,並刺激了對配方和分銷的投資。
縮短儲存期
許多微生物肥料保存期限短、產品穩定性差,導致儲存、運輸和庫存管理複雜,限制了市場擴張。活性微生物在高溫、乾燥或長期儲存條件下會失去活性,降低田間肥效,削弱農民信心。這增加了物流成本,提高了對低溫運輸和防腐劑的需求,並限制了分銷,尤其是在炎熱或偏遠地區。此外,配方劣化導致的田間肥效不穩定也會減緩推廣應用,並增加監管審查,因此,改進配方科學和包裝對於擴大商業應用規模至關重要。
發現更強大、更有效的微生物菌株
發現並商業化更穩健、用途更廣的微生物菌株,為該產業帶來了巨大的成長機會。菌株篩檢、微生物群落設計和製劑科學的進步,能夠培育出具有更高抗逆性、更強活力和更適合作物生長的微生物。兼具營養物質活化和病原體抑制功能的新型菌株,能夠提供組合式價值提案減少農民對化學投入品的依賴。增加研發投入、進行田間示範和完善監管途徑,將加速產品推廣,從而實現差異化產品、更強的功效宣稱,並促進不同種植系統中農民的快速採用。
來自大型化學企業的激烈競爭
來自現有化肥和農藥企業的激烈競爭對純粹的生物肥料供應商構成重大威脅。這些企業擁有龐大的分銷網路、雄厚的研發預算以及與農民的牢固關係,使其能夠捆綁產品、制定極具競爭力的價格,並迅速推出自有品牌產品。此外,熟悉的監管環境和值得信賴的品牌也進一步加劇了消費者對現有企業的偏好。為了捍衛市場佔有率,生物技術公司必須透過田間試驗、可靠的數據和密集的農民培訓來展現其明顯的農藝優勢,同時還要建立經銷夥伴,並抵消化肥和農藥生產商的規模經濟優勢。
疫情擾亂了供應鏈和農田作業,導致生物肥料生產商在短期內生產和分銷受阻。旅行限制和勞動力短缺延緩了田間試驗,並限制了原料採購,而農民則優先考慮提高短期產量的投入品。然而,人們對糧食安全和韌性的日益重視重新燃起了對生物解決方案的興趣。疫情後的復甦推動了對更具韌性的供應鏈和數位化推廣服務的投資,從而促進了需求的恢復和生物基農業投入品的長期應用。
預計在預測期內,液體燃料部分將是最大的組成部分。
預計在預測期內,液體製劑將佔據最大的市場佔有率,因為液體製劑更易於施用,可與灌溉和葉面噴布系統相容,並能提供更均勻的微生物分佈。農民偏好液體製劑,因為它們能快速被田間吸收,易於整合到灌溉系統中,且便於罐混。載體技術和防腐劑的改進緩解了過去的穩定性問題,使其更加可靠。大型商業農場和精準施肥系統更傾向於精確的液體製劑劑量,因此液體製劑的採用率很高,並鞏固了其在液體製劑領域的市場主導地位。
預計種子處理領域在預測期內將實現最高的複合年成長率。
預計在預測期內,種子處理行業將呈現最高的成長率,因為種子處理能夠以最小的額外勞動力投入,提供早期高效的保護和促進生長。播種時施用微生物可將微生物直接輸送到種子與根系的界面,從而提高微生物的定殖率和養分吸收,因此深受連續種植者和園藝種植者的青睞。載體和包衣技術的進步提高了微生物在儲存和播種過程中的存活率。此外,種子處理與病蟲害綜合治理和機械化播種相結合,與其他施用方法相比,推動了其快速普及和相對較高的成長。
在預測期內,北美預計將佔據最大的市場佔有率,這得益於其先進的農業基礎設施、完善的分銷管道以及對永續農業的強力的製度支持。大型商業農場、高農民收入以及充滿活力的研發生態系統加速了產品的測試和推廣應用。政策獎勵、有機耕地溢價以及領先生物肥料生產商的存在進一步提高了產品的可及性和市場信心。這些因素共同創造了成熟的商業環境,從而推動了生物基投入品的廣泛應用,並使其佔據了主導的市場佔有率。
預計亞太地區在預測期內將實現最高的複合年成長率,耕地面積擴大、糧食需求成長、農村交通便利化程度提高以及政府支持力度加大,都推動了相關技術的快速普及。本地新興企業和全球公司正在推出低成本、在地化的配方產品,而推廣服務和私部門培訓則促進了農民的採納。亞太地區是成長最快的區域市場,這得益於其龐大的潛在人口和日益成長的機械化水平,從而能夠實現快速規模化發展。
According to Stratistics MRC, the Global Biofertilizers & Biopesticides Market is accounted for $9.2 billion in 2025 and is expected to reach $18.9 billion by 2032, growing at a CAGR of 10.9% during the forecast period. Biofertilizers and biopesticides leverage beneficial microbes, entomopathogens, and botanical extracts to improve nutrient cycling, suppress pathogens, and enhance soil health as alternatives to synthetic chemicals. They support regenerative agriculture and reduced residue in food while enabling ecosystem services. Market growth is enabled by sustainability policies, consumer demand, and formulation innovations that increase stability and shelf life.
According to the United States Department of Agriculture (USDA), the use of biofertilizers and biopesticides in U.S. crop production increased by 12% between 2017 and 2022.
Rising demand for organic food
Rising consumer demand for organic and residue-free food is a primary driver for the biofertilizers and biopesticides market. Farmers and food brands increasingly adopt microbial inputs to meet regulatory standards and consumer expectations for sustainability, reduced chemical residues, and cleaner labels. This buyer preference raises field trials, procurement budgets, and collaborations between agri-input firms and biotech developers. Moreover, price premiums and export opportunities for organic produce improve farmer economics, making bio-based inputs commercially attractive and accelerating investment into formulation and distribution.
Shorter shelf life
Shorter shelf life and product stability for many microbial biofertilizers constrain market expansion by complicating storage, transport, and inventory management. Live microbes can lose viability under heat, desiccation, or prolonged storage, reducing field efficacy and farmer confidence. This raises logistics costs, increases cold-chain or preservative needs, and limits distribution reach especially in hot or remote regions. Moreover, variability in on-farm performance linked to degraded formulations slows adoption and invites greater regulatory scrutiny, making formulation science and improved packaging essential to scale commercial use.
Discovery of more robust and effective microbial strains
Discovery and commercialization of more robust, multi-functional microbial strains offer a substantial growth opportunity for the sector. Advances in strain screening, microbial consortia design, and formulation science can deliver microbes with improved stress tolerance, survival, and broader crop compatibility. Novel strains that combine nutrient mobilisation with pathogen suppression enable bundled value propositions that reduce farmers' dependence on chemical inputs. Increased R&D funding, field demonstrations, and regulatory pathways can accelerate product rollouts, enabling differentiated offerings, stronger efficacy claims, and faster farmer adoption across cropping systems.
Strong Competition from Chemical Giants
Strong competition from established chemical fertilizer and agrochemical companies represents a material threat to specialist biofertilizer vendors. Incumbents hold deep distribution networks, large R&D budgets, and strong farmer relationships; they can bundle offerings, employ aggressive pricing, and rapidly launch bio-branded lines. Regulatory familiarity and trusted brands further tilt buyer preference toward incumbents. To defend market share, biotech firms must demonstrate clear agronomic benefits through local trials, robust data, and intensive farmer training while building distribution partnerships that neutralise the scale advantages of chemical players.
The pandemic disrupted supply chains and field operations, creating short-term production and distribution setbacks for biofertilizer manufacturers. Travel restrictions and labour shortages delayed field trials and constrained raw-material sourcing, while farmers prioritised immediate yield inputs. However, increased attention to food security and resilience spurred renewed interest in biological solutions. Post-pandemic recovery saw investment in more resilient supply chains and digital extension services, supporting recovery of demand and longer-term adoption of bio-based agricultural inputs.
The liquid segment is expected to be the largest during the forecast period
The liquid segment is expected to account for the largest market share during the forecast period because liquid products offer simpler application, compatibility with fertigation and foliar systems, and more uniform microbial distribution. Farmers favour liquids for rapid field uptake, integration into irrigation, and ease of tank mixing, which reduces labour and application complexity. Improvements in carrier technologies and preservatives have mitigated past stability issues, increasing confidence. Large commercial farms and precision systems prefer liquid dosing for accuracy, which supports higher adoption and solidifies the liquid segment's dominant market position.
The seed treatment segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the seed treatment segment is predicted to witness the highest growth rate because seed applications deliver early, efficient protection and growth promotion with minimal added labour. Applying microbes at sowing places them directly at the seed-root interface, improving establishment and nutrient uptake advantages valued by both row-crop and horticultural producers. Advances in carriers and pelleting technologies have improved microbial survival during storage and planting. Moreover, seed treatment integrates well with integrated pest management and mechanised sowing, driving faster adoption and higher relative growth than other application methods.
During the forecast period, the North America region is expected to hold the largest market share driven by advanced agricultural infrastructure, well-developed distribution channels, and strong institutional support for sustainable farming. Large commercial farms, high farm incomes, and active R&D ecosystems accelerate product testing and uptake. Policy incentives, organic acreage premiums, and presence of major biofertilizer manufacturers further improve availability and trust. Together these factors create a mature commercial environment where bio-based inputs achieve broad adoption and capture a leading share of the market.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR because expanding arable area, rising food demand, improving rural connectivity, and stronger government support drive rapid adoption. Local startups and global firms are launching low-cost, locally adapted formulations while extension services and private sector training boost farmer acceptance. High addressable populations and increasing mechanisation make the region fertile for rapid scale-up, positioning Asia Pacific as the fastest-growing regional market.
Key players in the market
Some of the key players in Biofertilizers & Biopesticides Market include Bayer AG, BASF SE, Syngenta AG, Corteva Agriscience, FMC Corporation, UPL Limited, Marrone Bio Innovations, Inc., Valent BioSciences LLC, Certis USA LLC, Novozymes A/S, Koppert Biological Systems B.V., Andermatt Biocontrol AG, BioWorks, Inc., Lallemand Inc., Bioceres Crop Solutions Corp., and Rizobacter Argentina S.A.
In October 2025, Bayer CropScience launched the world's first bioinsecticide for arable crops, highlighting its commitment to sustainable farming and increased biological insecticide adoption. Bayer is focusing research and production in Germany on strategic technologies to maintain competitiveness amid significant industry challenges. It has also filed for regulatory approvals for new herbicide molecules in major markets while continuing legal strategies related to glyphosate liabilities.
In June 2025, Syngenta AG announced it is significantly expanding its research & development capabilities in agricultural biologicals, including acquiring assets (natural compounds and genetic strains) from Novartis AG for agricultural biological use.
In April 2024, Bayer AG signed an agreement with AlphaBio Control securing exclusive rights to market a new biological insecticide for arable crops (oilseed rape and cereals), targeting pests such as the cabbage stem flea beetle.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.